Skip to main content

Advertisement

Table 2 Clinical characteristics of TLE patients and post-mortem controls

From: DNA methyltransferase isoforms expression in the temporal lobe of epilepsy patients with a history of febrile seizures

Controls Gender Age (years) PMI (h) Cause of death Resection side
 C1302 Male 62 20 Sepsis Right
 C1303 Male 66 39 Heart failure Right
 C1304 Male 76 14 Sepsis Left
 C1401 Male 80 22 Heart failure Right
 C1402 Male 66 14 Sepsis Right
 C1403 Male 61 19 Heart failure Right
 C1404 Female 84 13 Abdominal carcinoma Right
 C1405 Female 64 42 COPD Right
 C1406 Female 85 17 Lung carcinoma Right
 C1407 Male 83 12 Heart failure Right
TLE patients Gender Age at surgery (years) Age of onset (years) Duration Pathology Antiepileptic drugs
 E1011 Male 58 53 5 HS- VPA, CBZ, LTG, LEV
 E1013 Female 51 24 27 HS- LEV, CBZ, LTG
 E1016 Male 37 31 6 HS- LEV, VPA, CBZ, LTG
 E1107 Female 60 17 43 HS- LTG, CBZ, LEV, CLB
 E1204 Female 40 16 24 HS- PHT, DZP, OXC, CLZ
 E1205 Male 20 N/A N/A HS- N/A
 E1206 Male 47 31 16 HS- CLB, OXC, LEV
 E1207 Male 29 20 9 HS- OXC, LEV
 E1214 Female 39 30 9 HS- LTG, CBZ
 E1302 Female 21 20 1 HS- LEV, LAC
 E1306 Female 59 7 52 HS- CBZ, CLB
 E1319 Female 41 27 14 HS- LEV, CBZ, CLB
 E1402 Female 21 1 20 HS- CLE, LEV
 E1404 Male 19 8 8 HS- CBZ, CLZ, LEV
 E1009 Female 39 4 35 HS+ DZP, CLB, LEV, OXC
 E1018 Male 63 2.5 60.5 HS+ CBZ, CLB, PHT, CLZ
 E1019 Female 43 3 40 HS+ LTG, CLZ, DZP, LEV, CLB
 E1103 Female 58 54 4 HS+ LTG, LEV, OXC, CBZ
 E1104 Male 47 3 44 HS+ LEV, PHT
 E1217 Male 54 17 37 HS+ FLU, LTG, MET, ZOP
 E1218 Male 28 4 24 HS+ CBZ, LTG
 E1312 Female 23 19 4 HS+ MDZ
 E1318 Female 47 11 36 HS+ LTG, CLB, TMP, VPA
 E1407 Male 55 10 45 HS+ MDZ, CBZ, CLB, LEV
 E0109 Male 48 30 18 HS+FS+ LTG, CLB, TPM
 E0705 Female 23 6 16 HS+FS+ LEV, LTG, CLB
 E0707 Female 59 N/A N/A HS+FS+ OXC, CLB, LEV
 E1014 Female 50 47 3 HS+FS+ OXC, LEV, CLB
 E1017 Female 23 1 22 HS+FS+ LTG, TPM, CLB, OXC
 E1213 Male 60 2 58 HS+FS+ CBZ, VPA, LTG, DZP
 E1219 Male 36 9 27 HS+FS+ LEV, VPA, OXC
 E1221 Female 41 4 37 HS+FS+ CLZ, CBZ
 E1305 Female 20 1 19 HS+FS+ MDZ, LEV, TMP
 E1310 Female 43 28 15 HS+FS+ LEV, LTG, CLB
 E1314 Male 42 8 34 HS+FS+ LTG, CLB
 E1408 Male 33 0 33 HS+FS+ CBZ, CLB, MDZ
 E1416 Female 41 20 21 HS+FS+ LEV, LTG, CLB
  1. CBZ carbamazepine, CLB clobazam, CLZ clonazepam, DZP diazepam, FLU flupentixol, FS febrile seizures, HS hippocampal sclerosis, LAC lascosamide, LEV levotiracetam, LTG lamotrigine, MDZ midazolam, MET methotrimeprazine, OXC oxcarbazepine, PHT phenytoin, PMI post-mortem interval, TLE temporal lobe epilepsy, TPM topiramate, VPA valproic acid, ZOP zopiclone, N/A not available